Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

COWE vs. MSOS: which is better?

Bottom line

COWE vs MSOS: the short answer

COWE (Cambria Venture ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.

COWE is cheaper at 0.59% vs 0.78% — a difference of $19 a year per $10,000 invested.

Updated Nov 19, 2026

COWE vs MSOS side by side

COWEMSOS
TypeETFETF
Fund familyCambriaAdvisorshares
CategoryOtherOther
Expense ratio0.59%0.78%
Annual cost per $10k$59$78
10-yr cost on $10k (prospectus)—$927
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—+23.4%
5-yr return (annualized)—−33.6%
10-yr return (annualized)——
Best quarter—+102.2%
Worst quarter—−50.4%
Net assets (fund)—$1.0B
Number of holdings—61
Portfolio turnover—5%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

COWE and MSOS share none of their top holdings.

COWE top 10

    MSOS top 10

    1. Curaleaf Holdings Inc — 12.32%
    2. Trulieve Cannabis Corp — 9.56%
    3. Blackrock Treasury Trust — 5.78%
    4. Terrascend Corp — 2.70%
    5. Marex Capital Markets Inc. — 2.16%
    6. Cantor Fitzgerald & Co. — 1.08%
    7. Morgan Stanley & Co. Llc — 0.94%
    8. Glass House Brands Inc — 0.93%
    9. Nomura Securities International, Inc. — 0.85%
    10. Cantor Fitzgerald & Co. — 0.78%

    FAQ

    What is the difference between COWE and MSOS?
    COWE (Cambria Venture ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs. COWE is cheaper at 0.59% vs 0.78% — a difference of $19 a year per $10,000 invested.
    Which is cheaper, COWE or MSOS?
    COWE has the lower expense ratio (0.59%).
    Should I own both COWE and MSOS?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.